Table 1 below shows the baseline characteristics of patients enrolled in the AGenotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI Studypublished in NEJM on Sept. 3, 2019.Looking the same research paper at Table 1, what statistical test can be likely used tocompare the mean age in the genotype-guided vs. standard-treatment groups